Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Witnesses tell House health subcommittee wearables, remote monitoring and AI can cut hospitalizations and costs
Loading...
Summary
Witnesses at a House health subcommittee hearing urged lawmakers to support remote patient monitoring, wearables and AI as tools to reduce hospital readmissions and health-care costs, while several members warned access and payment policy must be addressed for benefits to reach rural and low‑income patients.
Witnesses at a House health subcommittee hearing on digital health said wearables, remote patient monitoring (RPM) and artificial intelligence can reduce hospitalizations, improve chronic‑condition management and lower health‑care spending — but emphasized those gains depend on coverage, reimbursement and privacy safeguards.
Dr. Kristen Holmes, principal scientist and global head of human performance at Whoop, told the panel that wearable data is shifting care from episodic to continuous. "Wearable biometric data is transforming from novelty to necessity," she said, adding that wearables can support research and earlier intervention for conditions ranging from infection to preterm birth.
Why it matters: Witnesses offered specific examples and early‑stage outcome estimates that members said could translate into large system‑level savings if adoption and payment policies expand access. Several members pushed back that innovations alone will not help people who lose insurance or cannot afford care.
Most important claims and evidence - Whoop: Holmes cited studies and pilots that her company and academic partners have published, and told members Whoop is developing tools that fuse continuous physiologic signals with biomarkers. She said wearables can improve diabetes treatment and cited published research linking wearable use to treatment adherence and reduced costs. - RPM providers: Andrew Zangolowski, cofounder and CEO of CoachCare, described RPM as "an extension of the clinical staff" and said his company reduced hospitalizations among a cohort of 450 patients with chronic heart failure from 19.8% to 1.7%. He added, "I can monitor a patient for 50 years for the cost of an ambulance ride and a few days in the hospital." - Clinical IT: Jackie Gerhardt, chief medical officer at Epic, described how patient device data can flow into electronic health records and cited large exchange volumes: she said Epic customers exchanged roughly 700,000,000 patient records in a recent month and responded to more than 111,000,000,000 interoperability calls last year.
Supporting detail Committee members and witnesses described several concrete benefits: earlier detection of infections and preterm birth signals from wearables, remote titration of medications for hypertension and heart failure, and administrative savings from AI that can draft clinical notes or find documentation needed for prior authorization. Zangolowski and Gerhardt both stressed that clinical oversight is required: consumer wearables provide context but clinical decisions should rely on FDA‑cleared devices and clinician review.
Caveats and implementation challenges Lawmakers and witnesses repeatedly flagged three barriers: (1) coverage and payment. Zangolowski urged action to modernize Medicare and RPM reimbursement and warned that continuing cuts to Medicare and technology‑related services have strained small providers. (2) Access for rural and low‑income populations. Witnesses and members said affordability, broadband and workforce shortages limit reach. (3) Privacy and data validity. Gerhardt noted HIPAA does not cover all apps and urged clearer rules for entities exchanging patient data.
Audience and next steps Members pressed witnesses on policy responses: expanding reimbursement pathways (including clearer, faster Medicare coverage), preserving research funding and guarding privacy while maintaining innovation zones such as the 21st Century Cures Act and FDA guidances for general wellness products. Several members asked for follow‑up written answers and documents; the chair closed by advising members will submit written questions for the record.
Ending Witnesses framed digital health as a tool to shift care toward prevention and continuous management, but emphasized that policy choices on payment, privacy and access will determine whether the technologies reach patients who need them most.
